REVVITY, INC. (RVTY)

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Address

940 WINTER STREET
WALTHAM, MA 02451

Founded

1937

Number of Employees

11,500

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )
- - - $1,026 $52,456 $112 $116 $60 $24,501 $4,939 - $11,887
Average Price - - - $65.39 $80.33 $85.34 $128.58 $184.37 $134.16 $107.59 - $92.48
# Shares Purchased - - - 15,695 653,000 1,314 901 323 182,619 45,905 - 128,537
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - - 86.6% 51.9% 43.0% -5.1% -33.8% -9.1% 13.4% - 31.9%
S&P 500 Return to Date - - - 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% - 71.8%
Excess Total Return - - - -43.2% -53.0% -50.1% -80.0% -65.5% -46.3% -17.9% - -39.9%
Quartile Rank
Percentile Rank - - - 65% 59% 56% 25% 22% 37% 53% - 62%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)